Tacedinaline Completed Phase 2 Trials for Multiple Myeloma (MM) Treatment

IndicationsStatusPurposePhase
CompletedTreatment2
clinicaltrials.gov IdentifierTitleDrugs
NCT00005624CI-994 in Treating Patients With Advanced Myeloma